Short-term results of platelet-rich plasma in the treatment of chronic anal fissure: Randomized controlled clinical study

Yükleniyor...
Küçük Resim

Tarih

2021

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Lippincott

Erişim Hakkı

info:eu-repo/semantics/embargoedAccess

Özet

Background: Anal fissure is one of the most common benign anal disorders, and medical treatments play an important role in its management.Objective: The purpose of this study was to investigate the short-term effects and success of platelet-rich-plasma in the treatment of chronic anal fissure.Design: The study is a two parallel-group, randomized, controlled clinical trial.Settings: The study was carried out in two tertiary university hospitals.Patients: Forty-four-patients with chronic anal fissure were randomly assigned to platelet-rich-plasma treatment or control group. Presenting symptoms and pain scores were recorded on enrolment. The control patient self-administered topical glyceryl trinitrate. Platelet-rich-plasma was injected locally in the intervention group followed by self-administered glyceryl trinitrate.Main outcome measures: Primary outcome measure is a reduction in pain scores.Results: On day 10 and one month after treatment, the mean pain score was significantly lower in the platelet-rich-plasma patients than in the controls (p=0.005 and p<0.005, respectively). By one month after treatment, mean pain score declined by 5.7 points in the platelet-rich plasma-treated group compared with a 4.1 mean pain score decline in the control group (mean difference:1.6 points [95% confidence interval;0.3-2.9]).According to the repeated-measures analyses, Pain scores decreased in both groups, but the decrease in the treatment group was statistically higher than the control group (p<0.001).Complete epithelialization and recovery rates were significantly higher in the platelet-rich-plasma group than in controls at all follow-up times, with p-values ranging from 0.034 to<0.001.The observed difference in complete epithelialization after two months of treatment between the platelet-rich-plasma group and the control group was 56.2% with a 95% confidence interval of 14.03% to 98.4%.Limitations: This study was limited by its small sample size and long-term follow-up of the patients was not given.Conclusions: Platelet-rich-plasma reduced complaints and accelerated epithelialization and healing in patients with chronic anal fissures.

Açıklama

Anahtar Kelimeler

Botulinum Toxin, Chronic Anal Fissure, Lateral Internal Sphincterotomy, Medical Treatment, Platelet Rich Plasma

Kaynak

Diseases of the Colon & Rectum

WoS Q Değeri

Q1

Scopus Q Değeri

Q1

Cilt

64

Sayı

6

Künye

Yılmaz, G. ve Tanrıkulu, Y. (2021). Short-term results of platelet-rich plasma in the treatment of chronic anal fissure: Randomized controlled clinical study. Diseases of the Colon & Rectum, 64(6), 714-723. https://dx.doi.org/10.1097/DCR.0000000000001903